Copyright © 2017 IQVIA. All rights reserved. M01 2018 Facts from IQVIA
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Copyright © 2017 IQVIA. All rights reserved.
M01 2018Facts from IQVIA
1Indicator RUB USD EUR PACKSValue M01/YTD 2018, Bln. 73 1,3 1,1 0,4Growth M01/YTD,% -19% -14% -25% -8%
Market decreases by -19% in value and -8,3% in volumeRussia pharma market growth in January 2018
Source: IQVIA databases. Total Market. (exclude food supplements and diagnostic agents), TRD Prices
58 56198-19%
M01/YTD’1873
6 56M01/YTD’17905 Regional ReimbursementReimbursementPublic (EXCL. DLO AND RLO)Retail 0,38 0,35
-8,3%M01/YTD’18
0,400,03M01/YTD’17
0,430,04
VALUE, BLN RUB VOLUME, BLN PACKS
23%-74%-3,4%-23% 24%-9,0%
-8,4%-11%
2
Retail Sell-In: Share of Pharmacy chains in Retail Sell-In is 84% in value and 79% in volumeRussia retail market structure in January 2018
Source: IQVIA Retail Audit. Retail Market in Russia (exclude food supplements and diagnostic agents), Trd Prices
VALUE, BLN RUB VOLUME, BLN PACKS
9(16%)M01/YTD’18
5647(84%)
Individual pharmaciesPharmacy Chains M01/YTD’18
0,40,1(21%)0,3(79%)
3
Retail Sell-Out: Market grew by 1,6% in value and -0,4% in volumeRussia retail market growth in January 2018
Source: IQVIA databases. Pharmatrend. Retail Market in Russia (exclude food supplements and diagnostic agents), FIN Prices
VALUE, BLN RUB YoY growth, % YoY growth, %VOLUME, BLN PACKS1,6%
M01/YTD’18
7547%53%
M01/YTD’17
7443%57%
OTC RX
-0,4%
M01/YTD’18
0,432%68%
M01/YTD’17
0,430%70%-5,5%
11%-2,8%5,1%
4
Month-Over-Month Growth Rates, volumeSell-In vs Sell-Out, OTC registered drugs
Source: IQVIA databases. Pharmatrend. OTC Retail Market in Russia (exclude food supplements and diagnostic agents), TRD and FIN Prices
16,7%19,9%12,1%
-8,2%-6,0%2,9%
-8,1%-25-20-15-10-50
5101520
2018/01-10,2%-17,5%
2017/12
10,0%
2017/11-5,9%
2017/10
4,0%-3,6%
2017/09
17,9%
2017/08
6,7%10,8%
2017/07
-1,4%
2017/06-5,4%-7,2%
2017/05-2,2%-1,9%
2017/04-7,2%-12,7%
2017/032017/02-5,3%
2017/01-11,9%-20,2%
Sell-In Sell-Out
5
TOP-15 corporations on Russian market, January 2018
Source: IQVIA databases. Total Market(exclude food supplements and diagnostic agents), TRD Prices
NYCOMED/TAKEDA 2,0%ASTRAZENECA 2,0%KRKA 2,0%PFIZER 2,0%GEDEON RICHTER 2,0%MENARINI 2,2%ABBOTT 2,2%GLAXOSMITHKLINE 2,2%OTCPHARM 2,5%SANDOZ 2,5%JOHNSON & JOHNSON 2,8%SERVIER 2,8%TEVA 3,2%BAYER HEALTHCARE 4,4%SANOFI-AVENTIS 4,4%Total pharma market 100,0%
13%-15% -2% 10%-1%-4%-5%-12%-17%-14%-23% -1%-3% 9%-23%-19%
0%-17% -2%-7%-8%-8%-8%-7%-13%-9% 9%-6%-1%-5%-11%-8%Value growth / decline Volume growth / decline1234567891011121314
Market share, M01/YTD’18
15
6
TOP-10 products by growth in advertisement investments in January 2018Total salesBln RUB Sales, Growth Y-to-Y
122%180%252%409%43.623%
68%71%79%48%68%
WOBENZYM 0,11NOVO PASSIT 0,13NASIVIN 0,10MAGNELIS B6 0,13MEZYM 0,22BRONCHO MUNAL 0,17HEXORAL 0,19DOCTOR MOM 0,13
PENTALGIN 0,35LOCERYL 0,18
-2% 9%-11,5%-15%-13,6% 6,0%-18% 61%30,4%33%Advertisement, Growth Y-to-Y
Source: Pharmatrend data, Mediascope data, FIN Prices
7
TOP-10 products by decline in advertisement investments in January 2018
Source: Pharmatrend data, Mediascope data, FIN Prices
Total salesBln RUB Sales, Growth Y-to-Y
-96%
-100%-100%-100%
-100%-100%-100%-100%-100%-100%0,09AMIXIN 0,18CORVALOL 0,15BALSAM GOLD STAR 0,11
0,18SINUPRET 0,19ANTIGRIPPINARBIDOL 0,10VOLTAREN 0,10THERAFLEX 0,15VENARUS 0,18GASTAL
-52,5% 5%-43,9% 8%-7,8% 36,7%-3,8%-40% -19%-39,3%Advertisement, Growth Y-to-Y
8
Rating of largest distributors by direct DRUG supply share (incl. reimbursement), 2017Rank Wholesaler Direct drug supply share, %2017 20161 Protek 18,36% 18,65%2 Katren 17,46% 18,30%3 Pulse 13,81% 13,08%4 R-Pharm 4,80% 4,80%5 Pharmkomplekt 4,51% 3,81%6 BSS 3,69% 4,18%7 Grand Capital 2,70% 1,81%8 Profitmed 2,09% 2,14%9 Irvin 2 1,70% 0,95%10 Euroservice 1,34% 1,44%Total 70,47% 69,18%
9
Excluding reimbursement drug provision
Rating of largest pharmacy chains and associations by the size of direct sales of drugs for 20171 Incl. AVE Group; Gorzdrav; A5 Group, Pharmacor2 incl. O3, Zhivika, DOMpharma3 Incl. Ozerki, Doctor Stoletov, Raduga
№ Regions Pharmacy chains and associations Number of outlets as of January 2018 MS in retail drug pharmaceutical market, % 2017 Drug sales growth 2017/ 2016 Indicator of the relative sales volume for the drug assortment for 2017 (regarding the leading audited company) Average check, RUB.1 79 ASNA 8365 14,72% 98,71% 2,785 357,002 13 APTEKI 36,61 1765 5,28% 8,01% 1 -3 49 Rigla2 2031 4,89% 28,65% 0,925 494,744 44 Erkapharm3 1240 3,86% 63,74% 0,730 -5 8 Neo-pharm 446 2,54% 50,18% 0,481 -6 25 April 870 1,98% 123,38% 0,375 430,017 7 Farmland 950 1,80% 26,15% 0,342 491,428 14 Farmakopeika-Tvoy Doctor 892 1,72% 8,70% 0,325 -9 55 Melodia Zdorovia 1262 1,49% 38,22% 0,282 338,0010 8 Sotsial'naya Apteka (Nektar) 337 0,94% 7,02% 0,179 438,81Total: 18 158 39,23% 50,56%
10Indicator KZT USD EUR PACKSValue M01/YTD 2018, Bln. 24 0,08 0,06 0,05Growth M01/YTD,% -33% -32% -41% -22%
Market decreases by -33% in value and -22% in volumeKazakhstan pharma market growth in January 2018
Source: IQVIA databases. Total Market. (exclude food supplements and diagnostic agents), TRD Prices
M01/YTD’1822-33%36
424 249 1M01/YTD’17 2 RetailFree & Co-PaymentHospital 0,05 0,04M01/YTD’170,01
0,06 -22%M01/YTD’180,00
0,05VALUE, BLN KZT VOLUME, BLN PACKS
-82%-8,8%-75% -86%
-15%-62%
11
TOP-15 corporations on Kazakhstan market, January 2018
Source: IQVIA databases. Total Market (exclude food supplements and diagnostic agents), TRD Prices
KRKA 1,9%STADA 2,1%WORLD MEDICINE 2,2%GLAXOSMITHKLINE 2,4%SERVIER 2,5%NOBEL-AFF 2,6%SANDOZ GROUP 2,7%MENARINI 2,8%GEDEON RICHTER 2,9%ABBOTT 3,2%BAYER HEALTHCARE 3,8%SANOFI-AVENTIS 4,2%NYCOMED/TAKEDA 4,3%TEVA 4,6%SANTO 5,4%Total pharma market 100,0%
-31%-26% -5%-39%-25%-43% -26% -5%-23% -8%-27%-35%-32%-18%-43%-33%
-2%-19%-32%
3%-18%-30%-14%-48% -22%
-14%-31%-40%-34%-22%-23%-10%Value growth / decline Volume growth / decline1234567891011121314
Market share, M01/YTD’18
15
12Indicator BLR USD EUR PACKSValue M01/YTD 2018, Bln. 0,2 0,08 0,06 0,03Growth M01/YTD,% 7% 5% -8% -3%
Market grew by 7,3% in value and -3,3% in volumeBelarus pharma market growth in January 2018
Source: IQVIA databases. Total Market. (exclude food supplements and diagnostic agents), TRD Prices
+7,3%M01/YTD’18
0,160,030,12
M01/YTD’170,150,020,12 HospitalRetail
-3,3%M01/YTD’18
0,030,030,03M01/YTD’170,00 0,030,00
VALUE, BLN BLR VOLUME, BLN PACKS1,7%35%
-4,7%+6,5%
13
TOP-15 corporations on Belarus market, January 2018
Source: IQVIA databases. Total Market (exclude food supplements and diagnostic agents), TRD Prices
2,1%MINSKINTERCAPS MRUE 2,3%BERLIN-CH/MENARINI 2,4%NATIVITA JLLC 2,4%GEDEON RICHTER 2,5%TAKEDA 2,5%BAYER HEALTHCARE 2,6%SANOFI 2,7%PHARMTECHNOLOGY LTD 2,8%GSK 2,9%PHARMLAND JV LTD 3,3%NOVARTIS 3,8%LEKPHARM JLLC 5,2%BORISOV ZMP 6,9%BELMEDPREPARATY RUE
OCTAPHARMA AG
8,4%Total pharma market 100,0%
62%1%18% 435%-12% 34%3%-19%-5% 11%-4% 16%-12% 1%6%7%
34%-14%-10%-1%-3% 3%-9%-5% 1%
8% 434%-4% 33%-7%-13%-3%Value growth / decline Volume growth / decline1234567891011121314
Market share, M01/YTD’18
15
14
Please Contact Us for More InformationSvetlana NikulinaSenior Sales [email protected]+7 499 272 05 00Anton KalyapinSenior Offering [email protected]+7 499 272 05 00Gennady UshakovClient Service [email protected]+7 499 272 05 00
Related Documents
